bioMérieux Launches GENE-UP® TYPER,an Innovative Diagnostic Solution for Food Industries to Rapidly Analyze the Root Causeof Contamination of Listeria monocytogenes

Rhea-AI Summary

bioMérieux has launched GENE-UP® TYPER, a real-time PCR solution for rapid pathogen detection and root cause analysis in the food industry. The innovative diagnostic solution helps food manufacturers quickly identify the source of Listeria monocytogenes contamination.

The system combines a specific assay with the AUGMENTED-DX web application, powered by machine learning and a comprehensive genomic database. After pathogen detection and strain isolation, DNA is extracted and amplified, generating analytical results that define unique strain identifiers and group identical strains into clusters. This enables tracking contamination sources and improving production process control.

The solution was developed in collaboration with Mérieux NutriSciences, which will retain co-exclusive rights for testing services. GENE-UP® TYPER LMO, the first assay targeting Listeria monocytogenes, is now available worldwide for food manufacturers.

Positive

• Launch of innovative diagnostic solution for food safety testing
• Machine learning and genomic database integration for enhanced accuracy
• Global availability of the GENE-UP® TYPER LMO assay
• Strategic partnership with Mérieux NutriSciences for testing services

Negative

• None.

Real-Time PCR* Solution Combines an Assay and a Web Application for Rapid Strain Characterization to Quickly Identify Root Cause Contamination Aiding in More Rapid Decision Making to Minimize Future Recurrence

MARCY-L'ÉTOILE, France, Feb. 13, 2025 /PRNewswire/ -- bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of GENE-UP^® TYPER, a real-time, cutting-edge PCR solution for rapid pathogen detection root cause analysis in the food industry.

Each year, an estimated 600 million people fall ill after consuming contaminated food, according to the World Health Organization (WHO)¹. These incidents not only pose serious health risks but also lead to costly recalls and reputational damage for food industries. Despite strict monitoring and control measures, contamination can still occur. By using root cause analysis solutions, food industries can identify breakdowns in processes and implement effective corrective actions to better prevent future contaminations.

GENE-UP^® TYPER is a real-time PCR solution for rapid strain characterization of microorganisms, for use on bioMérieux's GENE-UP^® system. This easy-to-use automated food pathogen detection solution helps speed up the decision-making process by providing faster insights on strain identity.

After a pathogen is detected during routine testing and the strains are isolated in a sample, DNA is extracted and amplified with the GENE-UP^® TYPER specific assay. The analytical result generated by the GENE-UP^® instrument is then transferred to the AUGMENTED-DX web application. Powered by machine learning, which combines cutting-edge algorithms with years of expertise embedded in a comprehensive genomic database, GENE-UP^® TYPER defines a unique address identifying the strain and groups identical strains into "clusters". The web application then progressively builds a history of the strain clusters present in the factory, allowing to trace back the source of contamination for an improved control of the production process.

"With more than 30 years of expertise in Industrial Applications, bioMérieux continues to heavily invest in disruptive science and technology to help the food processing industry keep pace with their rapidly changing environment. With GENE-UP^® TYPER, we bring to the market an innovative solution capable of rapidly identifying root causes through genomics and data utilization, participating in the collective effort to make the world a healthier place and fight against food insecurity. With our partner Mérieux NutriSciences, we share the same intent of reshaping the landscape of food safety and set augmented quality standards", explains Yasha Mitrotti, Executive Vice President, Industrial Applications, bioMérieux.

This breakthrough and patented solution has been developed over years of research, with valuable contributions from Mérieux NutriSciences, a long-term partner of bioMérieux belonging to Institut Mérieux as well, and a global leader in food safety, quality and sustainability. Mérieux NutriSciences will retain co-exclusive rights to perform testing in key geographies for the outsourced testing services channel, ensuring the solution is available to all food and beverage processors, whether they operate an internal laboratory or outsource pathogen testing.

GENE-UP^® TYPER LMO, the first assay targeting Listeria monocytogenes root causes using the GENE-UP^® system, is now available worldwide for food manufacturers.

¹ https://www.who.int/activities/estimating-the-burden-of-foodborne-diseases

* Polymerase Chain Reaction

ABOUT BIOMÉRIEUX
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2023, revenues reached €3.7 billion, with over 90% of sales outside of France.
bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in food, pharmaceutical and cosmetic products.
www.biomerieux.com.

bioMérieux is listed on the Euronext Paris stock market.
Symbol: BIM – ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP

CONTACTS

INVESTORS RELATIONS
Aymeric Fichet
Tel.: +33 (0)4 78 87 20 00
investor.relations@biomerieux.com
MEDIA RELATIONS
CORPORATE	U.S. / INDUSTRIAL APPLICATIONS	FRANCE
Romain Duchez	Maggie DiSantis	Laurence Heilbronn (Image 7)
Tel.: +33 (0)4 78 87 20 00	Tel. : +1 (331) 385-1332	Tel.: +33 (0)1 53 70 74 48
media@biomerieux.com	maggie.disantis@biomerieux.com	lheilbronn@image7.fr

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomerieux-launches-gene-up-typer-an-innovative-diagnostic-solution-for-food-industries-to-rapidly-analyze-the-root-cause-of-contamination-of-listeria-monocytogenes-302375381.html

SOURCE bioMérieux

FAQ

What is the purpose of bioMérieux's new GENE-UP® TYPER diagnostic solution?

GENE-UP® TYPER is designed for rapid pathogen detection and root cause analysis in the food industry, specifically helping identify and trace Listeria monocytogenes contamination sources.

How does the GENE-UP® TYPER system work for food contamination analysis?

The system works by extracting and amplifying DNA from isolated strains, using PCR technology and machine learning to identify unique strain patterns and group them into clusters through the AUGMENTED-DX web application.

When will GENE-UP® TYPER LMO be available for food manufacturers?

GENE-UP® TYPER LMO, the first assay targeting Listeria monocytogenes, is now available worldwide for food manufacturers.

What is the partnership between bioMérieux and Mérieux NutriSciences for GENE-UP® TYPER?

Mérieux NutriSciences has co-exclusive rights to perform testing services in key geographies, making the solution available to food processors whether they have internal labs or outsource testing.